Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
3.075
-0.055 (-1.76%)
At close: Aug 28, 2026, 4:00 PM EDT
3.150
+0.075 (2.43%)
After-hours: Aug 28, 2026, 7:42 PM EDT
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of $25.44 million as of August 28, 2026. Its market cap has decreased by -56.22% in one year.
Market Cap
25.44M
Enterprise Value
20.58M
1-Year Change
-56.22%
Ranking
Category
Stock Price
$3.08
ChartMarket Cap Chart
Since January 9, 2020, Quantum BioPharma's market cap has decreased from $53.50M to $25.44M, a decrease of -52.45%. That is a compound annual growth rate of -10.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 23.30M | -16.49% |
| Dec 31, 2025 | 27.90M | 304.35% |
| Dec 31, 2024 | 6.90M | -80.94% |
| Dec 29, 2023 | 36.20M | 20.67% |
| Dec 30, 2022 | 30.00M | -27.18% |
| Dec 31, 2021 | 41.20M | 108.08% |
| Dec 31, 2020 | 19.80M | -62.99% |
| Jan 9, 2020 | 53.50M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evaxion | 26.69M |
| BeyondSpring | 26.31M |
| Atossa Therapeutics | 26.25M |
| Enlivex | 25.70M |
| Marker Therapeutics | 24.59M |
| Tvardi Therapeutics | 24.41M |
| Genenta Science | 24.30M |
| Cellectar Biosciences | 23.91M |